ucsf logobch logo

Hythem Nawaytou, MBBCH

Pediatric Cardiology
Portrait of Hythem Nawaytou
Portrait of Hythem Nawaytou
ucsf logobch logo

Hythem Nawaytou, MBBCH

Pediatric Cardiology

On this page

About me

Dr. Hythem Nawaytou is a cardiologist who cares for children with pulmonary hypertension in the hospital as well as the clinic. He performs and interprets all types of echocardiography (ultrasound of the heart), including fetal echocardiograms (used to help diagnose and evaluate many heart conditions before birth).

Nawaytou's research focuses on ways to better diagnose children with pulmonary hypertension and follow their progress over time. He also studies the use of echocardiography to evaluate heart function.

Nawaytou earned combined bachelor of medicine and bachelor of surgery degrees at Cairo University's Kasr Alainy Faculty of Medicine. He completed a residency in pediatrics at State University of New York Downstate Health Sciences University, followed by a fellowship in pediatric cardiology at UCSF and a fellowship in advanced cardiac imaging at Children's Hospital of Philadelphia.

In his free time, Nawaytou enjoys painting.

Education & training

Board certification

  • Pediatric Cardiology, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Fellowship

  • Cardiovascular Imaging, Childrens Hospital of Philadelphia- GME
  • Pediatric Cardiology, UCSF Graduate Medical Education

Residency

  • Pediatrics, State University of NY Health Sci Ctr/Brooklyn
  • Cairo University Hospitals

Internship

  • Cairo University Hospitals

Degree

  • MBBCH, University of Cairo

My expertise

  • Specialties
    • Pediatric Cardiology
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.